Skip to main content
Retour
Watch Compare

Harvard Apparatus Regenerative Technology, Inc.

Qualité des données : 100%
HRGN
OTC Manufacturing Measuring & Analyzing Instruments
1,57 €
▼ 0,11 € (-6,26%)
Cap. Boursière: 27,64 M
Prix
1,57 €
Cap. Boursière
27,64 M
Fourchette du Jour
1,48 € — 1,48 €
Fourchette 52 Semaines
0,94 € — 2,22 €
Volume
2
Ouverture 1,48 €
Moyenne 50J / 200J
1,73 €
8,94% below
Moyenne 50J / 200J
1,74 €
9,47% below

Quick Summary

Points Clés

Negative free cash flow of -3,83 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)63,72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-593,43%
En dessous de la moyenne du secteur (-51,02%)
ROIC-424,13%
Net Margin-975,71%
Op. Margin-982,24%

Sécurité

Debt / Equity
N/A
Current Ratio1,86
Interest Coverage-864,38

Valorisation

PE (TTM)
-4,02
En dessous de la moyenne du secteur (-1,98)
P/B Ratio17,78
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -4,0 -2,0
P/B 17,8 5,1
ROE % -593,4 -51,0
Net Margin % -975,7 -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 63,72% Revenue Growth (3Y) 161,44%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 704 000,0 Net Income (TTM) -6,87 M
ROE -593,43% ROA -293,36%
Gross Margin N/A Operating Margin -982,24%
Net Margin -975,71% Free Cash Flow (TTM) -3,83 M
ROIC -424,13% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,86
Interest Coverage -864,38 Asset Turnover 0,30
Working Capital 751 000 Tangible Book Value 1,55 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,02 Forward P/E N/A
P/B Ratio 17,78 P/S Ratio 39,26
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -13,85%
Market Cap 27,64 M Enterprise Value 26,32 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,04
FCF / Share -0,22 OCF / Share -0,22
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 55,73%
SBC-Adj. FCF -5,91 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 704 000,0 430 000,0 103 000,0 — 0,0
Net Income -6,87 M -7,73 M -8,95 M -6,07 M -7,98 M
EPS (Diluted) — — -0,67 — -0,79
Gross Profit — — — — —
Operating Income -6,92 M -7,73 M -8,99 M -6,15 M -8,64 M
EBITDA — — — — —
R&D Expenses 2,65 M 2,31 M 3,06 M 1,74 M 1,59 M
SG&A Expenses — — — 4,41 M 7,04 M
D&A — — — — —
Interest Expense 8 000,0 38 000,0 14 000,0 — —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,68 M 4,44 M 2,61 M 2,40 M 1,87 M
Total Liabilities 1,62 M 1,22 M 968 000,0 1,41 M 4,90 M
Shareholders' Equity 1,06 M 3,22 M 1,65 M -3,19 M -3,03 M
Total Debt — — — — —
Cash & Equivalents 1,35 M 2,49 M 432 000,0 — —
Current Assets 1,83 M 3,23 M 783 000,0 1,59 M 1,59 M
Current Liabilities 1,53 M 1,02 M 968 000,0 1,36 M 4,84 M